Cargando…

Excess body weight is an independent risk factor for severe forms of COVID-19

BACKGROUND AND AIMS: Few studies distinguished the independent role of overweight/obesity or their associated-comorbidities in the evolution towards severe forms of COVID-19. Obesity as a unifying risk factor for severe COVID-19 is an emerging hypothesis. The aim of this study was to evaluate whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietri, Léa, Giorgi, Roch, Bégu, Audrey, Lojou, Manon, Koubi, Marie, Cauchois, Raphael, Grangeot, Rachel, Dubois, Noémie, Kaplanski, Gilles, Valéro, René, Béliard, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	COVID-19 in Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834365/ https://www.ncbi.nlm.nih.gov/pubmed/33421506 http://dx.doi.org/10.1016/j.metabol.2021.154703

Ejemplares similares

Unacylated Ghrelin is associated with the isolated low HDL-cholesterol obese phenotype independently of insulin resistance and CRP level
por: Nogueira, Juan-Patricio, et al.
Publicado: (2012)

Excess mortality from COVID-19: weekly excess death rates by age and sex for Sweden and its most affected region
por: Modig, Karin, et al.
Publicado: (2020)

Using excess deaths and testing statistics to determine COVID-19 mortalities
por: Böttcher, Lucas, et al.
Publicado: (2021)

Discrimination of COVID‐19 From Inflammation‐Induced Cytokine Storm Syndromes Using Disease‐Related Blood Biomarkers
por: Kessel, Christoph, et al.
Publicado: (2021)

Inequitable distribution of excess mortality during the COVID-19 pandemic in Korea, 2020
por: Kim, Jin-Hwan, et al.
Publicado: (2022)

Community factors and excess mortality in the COVID-19 pandemic in England, Italy and Sweden
por: Parkes, Brandon, et al.
Publicado: (2023)

Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age
por: Gianicolo, Emilio A. L., et al.
Publicado: (2021)

Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation
por: Razieh, Cameron, et al.
Publicado: (2021)

Commentary: Measuring excess mortality due to the COVID-19 pandemic: progress and persistent challenges
por: Helleringer, Stéphane, et al.
Publicado: (2021)

Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort
por: Caspersen, Ida Henriette, et al.
Publicado: (2022)

Excess deaths reveal the true spatial, temporal and demographic impact of COVID-19 on mortality in Ecuador
por: Cuéllar, Leticia, et al.
Publicado: (2021)

Tool for tracking all-cause mortality and estimating excess mortality to support the COVID-19 pandemic response
por: Mengjuan, Duan, et al.
Publicado: (2022)

Excess mortality during the COVID-19 outbreak in Italy: a two-stage interrupted time-series analysis
por: Scortichini, Matteo, et al.
Publicado: (2020)

Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population
por: Lundberg, Christina E, et al.
Publicado: (2023)

Excess all-cause mortality and COVID-19-related mortality: a temporal analysis in 22 countries, from January until August 2020
por: Achilleos, Souzana, et al.
Publicado: (2021)

Obesity in patients with COVID-19: a systematic review and meta-analysis
por: Huang, Yi, et al.
Publicado: (2020)

Metabolic impact of weight loss induced reduction of adipose ACE-2 – Potential implication in COVID-19 infections?
por: Li, Linna, et al.
Publicado: (2020)

Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
por: Hamer, Mark, et al.
Publicado: (2020)

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data
por: Zhu, Zhaozhong, et al.
Publicado: (2020)

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19
por: Watanabe, Mikiko, et al.
Publicado: (2020)

Commentary. Eliminating vitamin D deficiency during the COVID-19 pandemic: A call to action
por: Manson, JoAnn E., et al.
Publicado: (2020)

Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()
por: Ghoneim, Sara, et al.
Publicado: (2020)

Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis
por: Du, Yanbin, et al.
Publicado: (2021)

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
por: Chakhtoura, M., et al.
Publicado: (2020)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

The serum metabolome of COVID-19 patients is distinctive and predictive
por: Shi, Ding, et al.
Publicado: (2021)

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021)

Visceral fat is associated to the severity of COVID-19
por: Favre, Guillaume, et al.
Publicado: (2021)

Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study
por: Freuer, Dennis, et al.
Publicado: (2021)

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry
por: Spick, Matt, et al.
Publicado: (2022)

Drug repurposing in COVID-19: A review with past, present and future
por: Srivastava, Kamna, et al.
Publicado: (2021)

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
por: Calvisi, Stefania L., et al.
Publicado: (2021)

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic()
por: Loh, Charlotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4dm4ddro6kq0p4h8hlkamb67jp